Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
Vesta Therapeutics, Inc
Download detailed PDF Members: Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human hepatocytes) obtained from organ donor livers that are not suitable for whole organ transplantation. Clinicians in academic settings have found that, following administration, human hepatocytes engraft and create new functioning liver tissue, which may provide a bridge to transplant or in some cases, eliminate the need for a liver transplant. The Food and Drug Administration has allowed the Company's Investigational New Drug (IND) application for a Phase I clinical trial of cryopreserved, allogeneic human liver cells for the treatment of patients with cirrhosis and end-stage liver disease.
This page has been viewed 404 times since April 2007, the link to the organisation's website has been followed 89 times Recent Search Terms used to find this page: Vesta Therapeutics Inc | Vesta Therapeutics Inc | vesta theraputics durham | vesta therapeutics | vesta theraputics 919 | vesta therapeutics Durham | vesta therapeutics 2009 | phase 1 vesta therapeutics | . Search for more companies in Durham Search for more companies in North Carolina This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Vesta Therapeutics, Inc | ||||||||||||||||||||||||||
|